Review: Current trends and new approaches in the management of diabetes mellitus

Annals of Clinical and Laboratory Science

Volumn 30, Issue 4, 2000, Pages 339-345

  Kao, P C ^a   Wu, T J ^a   Ho, L L T ^a   Li, X J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diabetes mellitus; Diet; Exercise; Glucose tolerance; Hyperglycemia; Hypertension; Insulin; Proinsulin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLIMEPIRIDE; GLUCOSE; INSULIN; METFORMIN; PROINSULIN; SULFONYLUREA DERIVATIVE; TROGLITAZONE; ANTIDIABETIC AGENT;

BLOOD PRESSURE; CARDIOVASCULAR RISK; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LABORATORY TEST; LYMPHOCYTE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS;

EID: 0034305389     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
2. Relative efficacy of sulfonylurea, insulin and metformin therapy in newly diagnosed non-insulin-dependent diabetes with primary diet failure followed for six years
3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes
4. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies
5. A review
6. Effect of glucose and blood pressure control on complications of type 2 diabetes mellitus
7. Risk factors for stroke in type 2 diabetes mellitus: The United Kingdom Prospective Diabetes Study (UKPDS)
8. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes
9. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes
10. Lowering the risk of visual impairment and blindness
11. Metabolism effects of metformin in non-insulin-dependent diabetes mellitus
12. Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients
13. Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes
14. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-α) and PPAR-γ. Effect of PPAR-α activation on abnormal lipid metabolism in liver of Zucker fatty rats
15. Type 2 diabetes: An overview
16. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism
17. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo
18. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
19. Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer
20. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma
21. Interdomain communication regulating ligand binding by PPAR-γ
22. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients
23. Alpha-glucosidase inhibitors
24. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance
25. Clinical profile of glimepiride
26. Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM
27. [Lys(B28),-Pro(B29)]-Human insulin: A rapidly absorbed analogue of human insulin
28. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
29. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
30. Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations: The Alaska-Siberia Project
31. Some aspects of diabetes care in Chengdu
32. An epidemio-logical study on diabetes mellitus 1995-1996
33. Prevalence of diabetes mellitus and impaired glucose tolerance in Aborigines and Chinese in Eastern Taiwan
34. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian Men
35. Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups
36. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM
37. Hypertension in Japanese Americans: The Seattle Japanese-American community diabetes study
38. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men
39. Fasting plasma glucose in screening for diabetes in the Taiwanese population
40. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose
41. Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma
42. Proinsulin level in diabetes mellitus measured by a new immunochemiluminometric assay
43. C-peptide immunochemiluminometric assay developed from two seemingly identical polyclonal antisera
44. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men
45. Proinsulin as a marker for the development of NIDDM in Japanese-American men
46. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men
47. Glycaemic control in type 2 diabetes: The impact of body weight, beta-cell function and patient education
48. No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index: The NHLBI Family Heart Study
49. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: Implications for preventing coronary heart disease during the prediabetic state